Close

Publications

Sturkenboom, M; Bahri, P; Chiucchiuini, A; Grove Krause, T; Hahné, S; Khromava, A; Kokki, M; Kramarz, P; Kurz, X; LARSON, HJ; De Lusignan, S; Mahy, P; Torcel-Pagnon, L; Titievsky, L; Bauchau, V; ADVANCE consortium,;
2019
Vaccine, (2019).38 Sup, 10.1016/j.vaccine.2019.07.081.
Mathematical modelling of the epidemiological impact, budget impact and cost-effectiveness of novel tuberculosis vaccines on multidrug-resistant tuberculosis [Oral Presentation].
WEERASURIYA, C; Harris, R; BOZZANI, F; Gomez, GB; WHITE, R;
2019
International Journal of Tuberculosis and Lung Disease, (2019).23 10
How might novel vaccines for prevention of Tuberculosis disease impact multi-drug resistant tuberculosis burden? A mathematical modelling-based analysis of epidemiologic and health economic impact.
WEERASURIYA, C; Harris, R; SUMNER, T; MCQUAID, C; BOZZANI, F; Knight, G; Gomez, G; WHITE, R;
2019
(2019).
SCHMIDT, W-P; Devamani, CS; Rose, W; ALEXANDER, N; Prakash, JA J;
2019
Tropical Medicine & International Health, (2019).24 12 10.1111/tmi.13322.
CHAN, Y-WD; EDMUNDS, WJ; Chan, H-L; Wong, M-L; Au, K-WA; Chuang, S-K; Van Hoek, AJ; FLASCHE, S;
2019
Human vaccines & immunotherapeutics, (2019).16 3 10.1080/21645515.2019.1663121.
CAREY, ME; Diaz, ZI; Broadstock, M; Bailey, R; Bentsi-Enchill, AD; LARSON, HJ;
2019
CLINICAL INFECTIOUS DISEASES, (2019).69 Suppl 10.1093/cid/ciz483.
Modelling of the Epidemiological Impact of Novel Tuberculosis Vaccines on Multidrug-resistant Tuberculosis in China.
WEERASURIYA, C; Harris, R; SUMNER, T; MCQUAID, C; BOZZANI, F; Knight, G; Gomez, GB; WHITE, R;
2019
(2019).
Pollard, EJ M; PATTERSON, C; Russell, TL; Apairamo, A; Oscar, J; ArcĂ , B; DRAKELEY, C; Burkot, TR;
2019
Malaria journal, (2019).18 1 10.1186/s12936-019-2975-8.